Aviva’s Everpure Inc P Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$21.3M Buy
270,020
+2,758
+1% +$202K 0.03% 406
2026
Q1
$15.8M Buy
267,262
+7,230
+3% +$490K 0.03% 449
2025
Q4
$17.4M Buy
260,032
+13,901
+6% +$1.16M 0.03% 426
2025
Q3
$20.6M Buy
246,131
+14,890
+6% +$990K 0.04% 373
2025
Q2
$13.3M Buy
231,241
+14,806
+7% +$737K 0.03% 462
2025
Q1
$9.58M Buy
216,435
+29,679
+16% +$1.79M 0.02% 463
2024
Q4
$11.5M Buy
186,756
+109,089
+140% +$6.08M 0.03% 417
2024
Q3
$3.9M Buy
77,667
+13,396
+21% +$757K 0.01% 501
2024
Q2
$4.13M Buy
+64,271
New +$3.72M 0.01% 520

Other funds holding P

Aviva's P Position: Q2 2026 in Review

Aviva increased its Everpure Inc (P) stake by 1% in Q2 2026, buying an estimated $202K and bringing the position to 270,020 shares worth $21.3M. The position accounts for 0.03% of the portfolio, ranked #406.

Aviva first reported a position in P in Q2 2024 and has held it in 9 quarters since. 814 funds tracked by Wall St. Rank hold P as of Q2 2026.

  • Aviva held 270,020 shares of Everpure Inc worth $21.3M as of Q2 2026.
  • Aviva bought 2,758 Everpure Inc shares in Q2 2026, an estimated $202K.
  • Everpure Inc made up 0.03% of Aviva's portfolio in Q2 2026, its #406 holding.
  • Aviva first reported a position in Everpure Inc in Q2 2024 and has held it in 9 quarters since.
  • 814 funds tracked by Wall St. Rank held Everpure Inc as of Q2 2026.

Based on Aviva's 13F filing for Q2 2026, filed 13 Aug 2026.